Diversity In Clinical Trials
Diversity in Clinical Trials
Our vision is to be a catalyst in life science that powers greater diversity in clinical trials
Diversity in Clinical Trials Steering Committee
The mission of Medidata’s Diversity in Clinical Trials (DICT) Steering Committee is to broaden patient representation in clinical trials regardless of ethnicity, gender, geographic location or socio-economic status. Focus areas include: patient-facing initiatives, thought leadership and insights on the clinical trial diversity gap, and solutions through our products and services.
Expanding Our Patient Footprint in the Community
Tu Salud Tu Familia
Medidata experts speak about the importance of diversity in clinical trials at a variety of industry events, including SCOPE, SCRS, and more. We also convene key thought leaders from pharmaceutical companies, contract research organizations, patient advocates, and regulatory bodies (e.g. Food and Drug Administration) to highlight opportunities and solutions at Medidata NEXT events.
Hackathon and Our Products
DICT served as the theme of the 2018 NEXT NYC Hackathon. During the 24-hour event, participants learned about the lack of representation in clinical trials. As pharmaceutical, biotech companies, contract research organizations, and tech companies worked towards a solution, that context created a sense of purpose that inspired the group.
The winning team was from Bayer HealthCare Pharmaceuticals. Their vision was to produce a real-time dashboard to track clinical trial participant demographics. In addition, by being able to share incidents, prevalence and the diversity profile, they would be able to address historical barriers impacting minority patient’s willingness to participate in trials.
Members of the Medidata DICT Steering Committee and the Bayer Hackathon team continue their work to develop a proof of concept using Medidata’s platform.